Monitoring neurochemical signaling dynamics in the lymph node

Information

  • Research Project
  • 10263279
  • ApplicationId
    10263279
  • Core Project Number
    R01AI151552
  • Full Project Number
    5R01AI151552-02
  • Serial Number
    151552
  • FOA Number
    PA-19-056
  • Sub Project Id
  • Project Start Date
    9/14/2020 - 3 years ago
  • Project End Date
    8/31/2025 - a year from now
  • Program Officer Name
    ESCH, THOMAS R
  • Budget Start Date
    9/1/2021 - 2 years ago
  • Budget End Date
    8/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    8/2/2021 - 2 years ago

Monitoring neurochemical signaling dynamics in the lymph node

PROJECT SUMMARY Neurochemical signaling within immune organs, like the lymph node, remains challenging to probe with existing technology yet knowing the mechanisms and function of this signaling would positively impact our understanding of immunity. Our long-term goal is to understand neurochemical regulated immunity during inflammation, autoimmunity, and even depression. To achieve this goal, new analytical tools are needed which can capture rapid neurochemical signaling in intact immune organs with high spatial resolution. The specific objective of this proposal is to develop and validate methods using fast-scan cyclic voltammetry (FSCV) at carbon-based microelectrodes to detect norepinephrine, ATP, and melatonin in slices of the mesenteric lymph node (mLN). All three neurochemicals are important for either triggering or suppressing immune responses within the gut-immune system; however, the dynamics and mechanisms by which they function are not understood. The rationale for this proposal is that the development of new tools to monitor rapid neurochemical signaling in an intact mLN will provide knowledge of neuroimmune communication dynamics in the gut which could lead to sophisticated neurochemical-targeted therapies for gastrointestinal inflammation and an improved understanding of the gut-brain axis. The proposal will be completed by the following three specific aims: (1) Develop innovative electrochemical methods to detect and validate neuronal norepinephrine release in live mLN slices, (2) Develop anion-exchange doped carbon-fiber microelectrodes for sensitive ATP detection in the mLN, and (3) Develop fouling-resistant sensors for multiplexed detection of melatonin with catecholamines in the mLN. We will pursue these aims with an innovative approach combining the power of fast-scan cyclic voltammetry?s high temporal resolution and spatial resolution with detection in live slices of the lymph node. This work is also innovative because new carbon electrodes and surface chemistries will be developed for targeted-analyte detection. This work is significant because the tools developed will help shift the paradigm that immunomodulation is slow and will impact our understanding of neuroimmune communication mechanisms and dynamics, specifically within the gut-immune system. Tools to detect rapid concentrations fluctuations in norepinephrine, ATP, and melatonin are also significant because they are not only involved in immunomodulation in the immune system, but are heavily involved in signaling throughout the body. The tools are translatable to any biological system. The expected outcome is a new toolbox for high temporal resolution detection of neurochemicals in the lymph node which will lead to an improved understanding of the mechanism and function of neurochemical signaling in spatially-resolved regions of mLN during conditions of health and inflammation. This work will have a positive impact on how neuroimmune communication is studied, and will advance current knowledge of neurotransmitter regulated immunity leading to advancements in targeted immunotherapies for autoimmunity, cancer, and disease.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R01
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
    250000
  • Indirect Cost Amount
    133422
  • Total Cost
    383422
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NIAID:383422\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    BNVT
  • Study Section Name
    Bioengineering of Neuroscience, Vision and Low Vision Technologies Study Section
  • Organization Name
    UNIVERSITY OF CINCINNATI
  • Organization Department
    CHEMISTRY
  • Organization DUNS
    041064767
  • Organization City
    CINCINNATI
  • Organization State
    OH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    452210001
  • Organization District
    UNITED STATES